Traws Pharma
TRAW0.51301.35% ( -0.0070 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Traws Pharma(TRAW) predict that the EBIT is -6.946 M (--%), Beat estimate;the EPS is -0.53 (--%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITExceed expectations
-0.01B--
-0.01B--
+0.00B--%
EPSExceed expectations
-0.53--
-0.56--
+0.0300--%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf